MetLife Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$310K Buy
26,647
+1,752
+7% +$25K ﹤0.01% 2189
2026
Q1
$418K Sell
24,895
-345
-1% -$6.17K ﹤0.01% 1837
2025
Q4
$405K Hold
25,240
– – ﹤0.01% 1890
2025
Q3
$312K Sell
25,240
-3,901
-13% -$45.7K ﹤0.01% 2061
2025
Q2
$336K Hold
29,141
– – ﹤0.01% 1887
2025
Q1
$437K Sell
29,141
-453
-2% -$7.58K ﹤0.01% 1791
2024
Q4
$512K Buy
29,594
+2,388
+9% +$46.1K ﹤0.01% 1783
2024
Q3
$504K Sell
27,206
-396
-1% -$7.95K ﹤0.01% 1777
2024
Q2
$560K Buy
27,602
+2,848
+12% +$50.4K ﹤0.01% 1665
2024
Q1
$423K Hold
24,754
– – ﹤0.01% 1768
2023
Q4
$437K Hold
24,754
– – ﹤0.01% 1770
2023
Q3
$594K Hold
24,754
– – ﹤0.01% 1524
2023
Q2
$576K Buy
+24,754
New +$560K ﹤0.01% 1599
2020
Q2
– Sell
-25,471
Closed -$263K – 2308
2020
Q1
$263K Hold
25,471
– – ﹤0.01% 1546
2019
Q4
$959K Sell
25,471
-331
-1% -$14.9K 0.01% 1119
2019
Q3
$1.2M Sell
25,802
-475
-2% -$22.1K 0.01% 980
2019
Q2
$1.37M Sell
26,277
-677
-3% -$39.7K 0.01% 973
2019
Q1
$1.86M Buy
+26,954
New +$1.81M 0.01% 1304

Other funds holding CLB

MetLife Investment Management's CLB Position: Q2 2026 in Review

MetLife Investment Management increased its Core Laboratories (CLB) stake by 7% in Q2 2026, buying an estimated $25K and bringing the position to 26,647 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

MetLife Investment Management first reported a position in CLB in Q1 2019 and has held it in 18 quarters since. The position peaked at $1.86M in Q1 2019. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • MetLife Investment Management held 26,647 shares of Core Laboratories worth $310K as of Q2 2026.
  • MetLife Investment Management bought 1,752 Core Laboratories shares in Q2 2026, an estimated $25K.
  • Core Laboratories made up ﹤0.01% of MetLife Investment Management's portfolio in Q2 2026, its #2189 holding.
  • MetLife Investment Management first reported a position in Core Laboratories in Q1 2019 and has held it in 18 quarters since.
  • MetLife Investment Management's Core Laboratories position peaked at $1.86M in Q1 2019.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.